GSR and cancer: A study conducted by Li et al. (2020) characterized BITC as a potential GR inhibitor in human cancer cells and demonstrated that BITC was evaluated as a competitive and irreversible GR inhibitor in a time- and concentration-dependent manner, and this reaction depended on the presence of NADPH [55].